Cencora (COR) Free Cash Flow Growth (3y) (2012 - 2026)
Cencora (COR) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 0.80% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 30.60% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 10.23% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -212.44% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -45.61% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -3.17% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -22.47% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 44.68% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.60% |
| Dec 31, 2025 | -79.90% |
| Sep 30, 2025 | 42.77% |
| Jun 30, 2025 | -31.05% |
| Mar 31, 2025 | 186.56% |
| Dec 31, 2024 | -77.63% |
| Sep 30, 2024 | -1.07% |
| Jun 30, 2024 | 29.53% |
| Mar 31, 2024 | -22.43% |
| Dec 31, 2023 | -1.07% |
| Sep 30, 2023 | 11.83% |
| Jun 30, 2023 | 74.26% |
| Mar 31, 2023 | -12.11% |
| Dec 31, 2022 | 103.29% |
| Sep 30, 2022 | 18.64% |
| Jun 30, 2022 | -16.03% |
| Mar 31, 2022 | -36.79% |
| Dec 31, 2021 | 25.16% |
| Sep 30, 2021 | 13.54% |
| Jun 30, 2021 | 13.44% |